-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Lifespan

Program: Trainee Activities and Services
Session: Career Development Lunch
Saturday, December 9, 2023, 11:15 AM-12:15 PM

Julie Kanter, MD

Division of Hematology and Oncology, University of Alabama, Birmingham, AL

Disclosures: Kanter: Austin Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees; ECOR-1: Consultancy; Guidepoint Global: Honoraria; National Alliance of Sickle Cell Centers: Other: President; Bausch: Consultancy; Glycomimetics: Membership on an entity's Board of Directors or advisory committees; Fulcurm: Consultancy; NHLBI: Research Funding; CDC: Research Funding; HRSA: Research Funding; Watkins, Lourie, Roll & Chance: Consultancy; BEAM: Consultancy, Research Funding; Takeda: Research Funding; Chiesi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Vertex: Consultancy; Bluebird Bio: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novo Nordisk: Research Funding; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding.